BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Patrick Arbuthnot. MicroRNA-like antiviralsBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2011; 1809(11-12): 746 doi: 10.1016/j.bbagrm.2011.05.006
Jennifer Louten, Michael Beach, Kristina Palermino, Maria Weeks, Gabrielle Holenstein. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsBiomarker Insights 2015; : BMI.S29512 doi: 10.4137/BMI.S29512
Mathieu Bergé, Philippe Bonnin, Eric Sulpice, José Vilar, David Allanic, Jean-Sébastien Silvestre, Bernard I. Lévy, Gordon C. Tucker, Gérard Tobelem, Tatyana Merkulova-Rainon. Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular CarcinomaThe American Journal of Pathology 2010; 177(6): 3192 doi: 10.2353/ajpath.2010.100157
David J. Pinato, Mario Pirisi, Lynn Maslen, Rohini Sharma. Tissue Biomarkers of Prognostic Significance in Hepatocellular CarcinomaAdvances In Anatomic Pathology 2014; 21(4): 270 doi: 10.1097/PAP.0000000000000029
Tracey M. Hinton, Paul Monaghan, Diane Green, Sander A.A. Kooijmans, Shuning Shi, Kerry Breheney, Mark Tizard, Joseph A. Nicolazzo, Alexander N. Zelikin, Kim Wark. Biodistribution of polymer hydrogel capsules for the delivery of therapeuticsActa Biomaterialia 2012; 8(9): 3251 doi: 10.1016/j.actbio.2012.05.028
N. Manjunath, Haoquan Wu, Sandesh Subramanya, Premlata Shankar. Lentiviral delivery of short hairpin RNAsAdvanced Drug Delivery Reviews 2009; 61(9): 732 doi: 10.1016/j.addr.2009.03.004
Qing Ge, John J Xu, David M Evans, A James Mixson, Harry Y Yang, Patrick Y Lu. Leveraging therapeutic potential of multi-targeted siRNA inhibitorsFuture Medicinal Chemistry 2009; 1(9): 1671 doi: 10.4155/fmc.09.131
Bo Yu, Shu-Hao Hsu, Chenguang Zhou, Xinmei Wang, Megan C. Terp, Yun Wu, Lesheng Teng, Yicheng Mao, Feng Wang, Weiming Xue, Samson T. Jacob, Kalpana Ghoshal, Robert J. Lee, Ly J. Lee. Lipid nanoparticles for hepatic delivery of small interfering RNABiomaterials 2012; 33(25): 5924 doi: 10.1016/j.biomaterials.2012.05.002
Paul Lingor. Apoptosome2010; : 95 doi: 10.1007/978-90-481-3415-1_5
Clifford J. Steer, Betsy T. Kren. The Future of Aging2010; : 641 doi: 10.1007/978-90-481-3999-6_21
Song He, Ying-ze Wei, Gui-lan Wang, Yu-yin Xu, Jia-ming Zhou, Yi-xin Zhang, Li Chen. Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma TherapyIn VitroandIn VivoGastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/685150
H.M. El Tayebi, K.A. Hosny, G. Esmat, K. Breuhahn, Ahmed Ihab Abdelaziz. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinomaFEBS Letters 2012; 586(19): 3309 doi: 10.1016/j.febslet.2012.06.054
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fictionWorld Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
Gray Kueberuwa, Ryan Cawood, Alison Tedcastle, Leonard W. Seymour. Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic StabilityHuman Gene Therapy Methods 2014; 25(2): 154 doi: 10.1089/hgtb.2013.202
Lanxia Liu, Hai Wang, Qi Liu, Mingli Duan, Xia Dong, Dunwan Zhu, Yingjun Zhu, Xigang Leng. Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenograftsJournal of Biomedical Materials Research Part A 2016; 104(10): 2394 doi: 10.1002/jbm.a.35775
Krishna K. Banaudha, Mukesh Verma. Cancer EpigeneticsMethods in Molecular Biology 2012; 863: 241 doi: 10.1007/978-1-61779-612-8_14
Xiaoxuan Liu, Lin Zhu, Jingjing Ma, Xinxiao Qiao, Dunwan Zhu, Lanxia Liu, Xigang Leng. Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptideDrug Delivery and Translational Research 2017; 7(1): 147 doi: 10.1007/s13346-016-0348-1
Mohube Betty Mowa, Carol Crowther, Patrick Arbuthnot. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activatorsExpert Opinion on Drug Delivery 2010; 7(12): 1373 doi: 10.1517/17425247.2010.533655
Dejana Ivacik, Abdullah Ely, Patrick Arbuthnot. Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Reviews in Medical Virology 2011; 21(6): 383 doi: 10.1002/rmv.705
G. Gonzalez-Aseguinolaza, J. Prieto, R. Hernandez-Alcoceba. Gene therapy of liver cancer: an updateJournal Africain du Cancer / African Journal of Cancer 2011; 3(3): 180 doi: 10.1007/s12558-011-0153-1
Xueling Ren, Yue Ma, Min Xu, Tingting Chen, Zhenzhong Zhang, Yun Zhang. Construction, modification and evaluation of apolipoprotein A-I promoter-driven shRNA expression vectors against hTERTPlasmid 2011; 65(1): 42 doi: 10.1016/j.plasmid.2010.11.001
Yan Li, Zhao-You Tang, Jin-Xuan Hou. Hepatocellular carcinoma: insight from animal modelsNature Reviews Gastroenterology & Hepatology 2012; 9(1): 32 doi: 10.1038/nrgastro.2011.196
Meng Zhao, Hong-wei He, Huan-xing Sun, Kai-huan Ren, Rong-guang Shao. Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cellsBiochemical and Biophysical Research Communications 2009; 387(2): 239 doi: 10.1016/j.bbrc.2009.06.128